Results of the Ielsg32 Trial at a Median Follow-up of 88 Months Demonstrate That Matrix Followed By Autologous Transplant is Associated with Excellent Survival and Neurotolerability in Patients with Primary Cns Lymphoma

T. Calimeri; K. Cwynarski; E. Pulczynski; C. P. Fox; E. Schorb; S. Steffanoni; M. Foppoli; C. Celico; M. Falautano; A. Nonis; P. La Rosee; M. Binder; A. Fabbri; F. Ilariucci; M. Krampera; A. Roth; C. Hemmaway; P. W. Johnson; K. M. Linton; T. Pukrop; J. Sonderskov Gorlov; M. Balzarotti; G. Hess; U. Keller; S. Stilgenbauer; J. Panse; A. Tucci; L. Orsucci; F. Pisani; M. Zanni; S. W. Krause; H. J. Schmoll; B. Hertenstein; M. Rummel; J. Smith; L. Thurner; G. Cabras; E. Pennese; M. Ponzoni; M. Deckert; L. S. Politi; J. Finke; A. Ferranti; K. Cozens; E. Burger; N. Ielmini; F. Cavalli; E. Zucca; G. Illerhaus; A. J. M. Ferreri

Results of the Ielsg32 Trial at a Median Follow-up of 88 Months Demonstrate That Matrix Followed By Autologous Transplant is Associated with Excellent Survival and Neurotolerability in Patients with Primary Cns Lymphoma

T. Calimeri, K. Cwynarski, E. Pulczynski, C. P. Fox, E. Schorb, S. Steffanoni, M. Foppoli, C. Celico, M. Falautano, A. Nonis, P. La Rosee, M. Binder, A. Fabbri, F. Ilariucci, M. Krampera, A. Roth, C. Hemmaway, P. W. Johnson, K. M. Linton, T. PukropJ. Sonderskov Gorlov, M. Balzarotti, G. Hess, U. Keller, S. Stilgenbauer, J. Panse, A. Tucci, L. Orsucci, F. Pisani, M. Zanni, S. W. Krause, H. J. Schmoll, B. Hertenstein, M. Rummel, J. Smith, L. Thurner, G. Cabras, E. Pennese, M. Ponzoni, M. Deckert, L. S. Politi, J. Finke, A. Ferranti, K. Cozens, E. Burger, N. Ielmini, F. Cavalli, E. Zucca, G. Illerhaus, A. J. M. Ferreri

Division of Cancer Sciences (L5)

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Pages (from-to)	33-33
Number of pages	1
Journal	Haematologica
Volume	106
Issue number	10
Publication status	Published - Oct 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

Calimeri, T., Cwynarski, K., Pulczynski, E., Fox, C. P., Schorb, E., Steffanoni, S., Foppoli, M., Celico, C., Falautano, M., Nonis, A., La Rosee, P., Binder, M., Fabbri, A., Ilariucci, F., Krampera, M., Roth, A., Hemmaway, C., Johnson, P. W., Linton, K. M., ... Ferreri, A. J. M. (2021). Results of the Ielsg32 Trial at a Median Follow-up of 88 Months Demonstrate That Matrix Followed By Autologous Transplant is Associated with Excellent Survival and Neurotolerability in Patients with Primary Cns Lymphoma. Haematologica, 106(10), 33-33.

@article{5dbf1feb419b408d95fd0bd9b011f769,

title = "Results of the Ielsg32 Trial at a Median Follow-up of 88 Months Demonstrate That Matrix Followed By Autologous Transplant is Associated with Excellent Survival and Neurotolerability in Patients with Primary Cns Lymphoma",

author = "T. Calimeri and K. Cwynarski and E. Pulczynski and Fox, {C. P.} and E. Schorb and S. Steffanoni and M. Foppoli and C. Celico and M. Falautano and A. Nonis and {La Rosee}, P. and M. Binder and A. Fabbri and F. Ilariucci and M. Krampera and A. Roth and C. Hemmaway and Johnson, {P. W.} and Linton, {K. M.} and T. Pukrop and {Sonderskov Gorlov}, J. and M. Balzarotti and G. Hess and U. Keller and S. Stilgenbauer and J. Panse and A. Tucci and L. Orsucci and F. Pisani and M. Zanni and Krause, {S. W.} and Schmoll, {H. J.} and B. Hertenstein and M. Rummel and J. Smith and L. Thurner and G. Cabras and E. Pennese and M. Ponzoni and M. Deckert and Politi, {L. S.} and J. Finke and A. Ferranti and K. Cozens and E. Burger and N. Ielmini and F. Cavalli and E. Zucca and G. Illerhaus and Ferreri, {A. J. M.}",

year = "2021",

month = oct,

language = "English",

volume = "106",

pages = "33--33",

journal = "Haematologica",

issn = "0390-6078",

publisher = "Ferrata Storti Foundation",

number = "10",

}

Calimeri, T, Cwynarski, K, Pulczynski, E, Fox, CP, Schorb, E, Steffanoni, S, Foppoli, M, Celico, C, Falautano, M, Nonis, A, La Rosee, P, Binder, M, Fabbri, A, Ilariucci, F, Krampera, M, Roth, A, Hemmaway, C, Johnson, PW, Linton, KM, Pukrop, T, Sonderskov Gorlov, J, Balzarotti, M, Hess, G, Keller, U, Stilgenbauer, S, Panse, J, Tucci, A, Orsucci, L, Pisani, F, Zanni, M, Krause, SW, Schmoll, HJ, Hertenstein, B, Rummel, M, Smith, J, Thurner, L, Cabras, G, Pennese, E, Ponzoni, M, Deckert, M, Politi, LS, Finke, J, Ferranti, A, Cozens, K, Burger, E, Ielmini, N, Cavalli, F, Zucca, E, Illerhaus, G & Ferreri, AJM 2021, 'Results of the Ielsg32 Trial at a Median Follow-up of 88 Months Demonstrate That Matrix Followed By Autologous Transplant is Associated with Excellent Survival and Neurotolerability in Patients with Primary Cns Lymphoma', Haematologica, vol. 106, no. 10, pp. 33-33.

Results of the Ielsg32 Trial at a Median Follow-up of 88 Months Demonstrate That Matrix Followed By Autologous Transplant is Associated with Excellent Survival and Neurotolerability in Patients with Primary Cns Lymphoma. / Calimeri, T.; Cwynarski, K.; Pulczynski, E. et al.
In: Haematologica, Vol. 106, No. 10, 10.2021, p. 33-33.

Research output: Contribution to journal › Meeting Abstract › peer-review

TY - JOUR

T1 - Results of the Ielsg32 Trial at a Median Follow-up of 88 Months Demonstrate That Matrix Followed By Autologous Transplant is Associated with Excellent Survival and Neurotolerability in Patients with Primary Cns Lymphoma

AU - Calimeri, T.

AU - Cwynarski, K.

AU - Pulczynski, E.

AU - Fox, C. P.

AU - Schorb, E.

AU - Steffanoni, S.

AU - Foppoli, M.

AU - Celico, C.

AU - Falautano, M.

AU - Nonis, A.

AU - La Rosee, P.

AU - Binder, M.

AU - Fabbri, A.

AU - Ilariucci, F.

AU - Krampera, M.

AU - Roth, A.

AU - Hemmaway, C.

AU - Johnson, P. W.

AU - Linton, K. M.

AU - Pukrop, T.

AU - Sonderskov Gorlov, J.

AU - Balzarotti, M.

AU - Hess, G.

AU - Keller, U.

AU - Stilgenbauer, S.

AU - Panse, J.

AU - Tucci, A.

AU - Orsucci, L.

AU - Pisani, F.

AU - Zanni, M.

AU - Krause, S. W.

AU - Schmoll, H. J.

AU - Hertenstein, B.

AU - Rummel, M.

AU - Smith, J.

AU - Thurner, L.

AU - Cabras, G.

AU - Pennese, E.

AU - Ponzoni, M.

AU - Deckert, M.

AU - Politi, L. S.

AU - Finke, J.

AU - Ferranti, A.

AU - Cozens, K.

AU - Burger, E.

AU - Ielmini, N.

AU - Cavalli, F.

AU - Zucca, E.

AU - Illerhaus, G.

AU - Ferreri, A. J. M.

PY - 2021/10

Y1 - 2021/10

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=pure_starter&SrcAuth=WosAPI&KeyUT=WOS:000719458000050&DestLinkType=FullRecord&DestApp=WOS_CPL

M3 - Meeting Abstract

SN - 0390-6078

VL - 106

SP - 33

EP - 33

JO - Haematologica

JF - Haematologica

IS - 10

ER -

Results of the Ielsg32 Trial at a Median Follow-up of 88 Months Demonstrate That Matrix Followed By Autologous Transplant is Associated with Excellent Survival and Neurotolerability in Patients with Primary Cns Lymphoma

UN SDGs

Other files and links

Cite this